SE8604112L - PHARMACEUTICAL PREPARATIONS WITH REGULATED RELEASE OF THE ACTIVE SUBSTANCE - Google Patents

PHARMACEUTICAL PREPARATIONS WITH REGULATED RELEASE OF THE ACTIVE SUBSTANCE

Info

Publication number
SE8604112L
SE8604112L SE8604112A SE8604112A SE8604112L SE 8604112 L SE8604112 L SE 8604112L SE 8604112 A SE8604112 A SE 8604112A SE 8604112 A SE8604112 A SE 8604112A SE 8604112 L SE8604112 L SE 8604112L
Authority
SE
Sweden
Prior art keywords
active substance
pharmaceutical preparations
regulated release
pharmaceutically acceptable
formulation
Prior art date
Application number
SE8604112A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE503222C2 (en
SE8604112D0 (en
Inventor
O Zuger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8604112D0 publication Critical patent/SE8604112D0/en
Publication of SE8604112L publication Critical patent/SE8604112L/en
Publication of SE503222C2 publication Critical patent/SE503222C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Case 100-6717 A controlled release formulation for oral administration comprising - an active substance chosen from the group of Pindolol and a 4-(2,1, 3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester, - a pharmaceutically acceptable hydrophilic swellable substance and containing optionally a pharmaceutically acceptable inert fatty material in addition. The formulation has an excellent bioavailability and practically no food interaction after administration. 3700/KD/AB
SE8604112A 1985-10-01 1986-09-29 Pharmaceutical preparations with controlled release of isradipine or darodipine SE503222C2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (3)

Publication Number Publication Date
SE8604112D0 SE8604112D0 (en) 1986-09-29
SE8604112L true SE8604112L (en) 1987-04-02
SE503222C2 SE503222C2 (en) 1996-04-22

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604112A SE503222C2 (en) 1985-10-01 1986-09-29 Pharmaceutical preparations with controlled release of isradipine or darodipine

Country Status (20)

Country Link
KR (1) KR920008817B1 (en)
AT (1) AT402257B (en)
BE (1) BE905516A (en)
CA (1) CA1298784C (en)
CH (1) CH669524A5 (en)
DE (1) DE3632201C2 (en)
DK (1) DK170016B1 (en)
ES (1) ES2002508A6 (en)
FR (1) FR2589732B1 (en)
GR (1) GR862457B (en)
HK (1) HK392A (en)
HU (1) HU197201B (en)
IE (1) IE59589B1 (en)
IL (1) IL80182A (en)
LU (1) LU86615A1 (en)
NL (1) NL194822C (en)
NZ (1) NZ217732A (en)
PT (1) PT83456B (en)
SE (1) SE503222C2 (en)
SG (1) SG103391G (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ATE409475T1 (en) * 2001-02-20 2008-10-15 Dinan Timothy Gerard TREATING FIBROMYALGIA WITH PINDOLOL
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
DD145004A3 (en) * 1978-09-25 1980-11-19 Reinhard Huettenrauch METHOD FOR PRODUCING SOLID A NOMENCLATES
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (en) * 1980-05-21 1985-12-09 塩野義製薬株式会社 sustained release formulation
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6124516A (en) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd Long active tablet

Also Published As

Publication number Publication date
KR870003777A (en) 1987-05-04
SG103391G (en) 1992-01-17
KR920008817B1 (en) 1992-10-09
IE59589B1 (en) 1994-03-09
SE503222C2 (en) 1996-04-22
IL80182A (en) 1991-01-31
NL194822C (en) 2003-04-03
IE862565L (en) 1987-04-01
DK170016B1 (en) 1995-05-01
HK392A (en) 1992-01-10
ES2002508A6 (en) 1988-08-16
FR2589732B1 (en) 1989-07-13
NZ217732A (en) 1990-07-26
DE3632201A1 (en) 1987-04-02
NL8602370A (en) 1987-05-04
FR2589732A1 (en) 1987-05-15
CA1298784C (en) 1992-04-14
HUT44701A (en) 1988-04-28
GR862457B (en) 1987-01-29
DK464686D0 (en) 1986-09-29
ATA260486A (en) 1996-08-15
PT83456A (en) 1986-10-01
HU197201B (en) 1989-03-28
LU86615A1 (en) 1987-04-02
AT402257B (en) 1997-03-25
CH669524A5 (en) 1989-03-31
PT83456B (en) 1989-05-12
DE3632201C2 (en) 1997-05-07
IL80182A0 (en) 1986-12-31
NL194822B (en) 2002-12-02
SE8604112D0 (en) 1986-09-29
DK464686A (en) 1987-04-02
BE905516A (en) 1987-03-30

Similar Documents

Publication Publication Date Title
IT1200178B (en) GALENIC FORMULATIONS WITH SCHEDULED SALE CONTAINING DRUGS WITH ANTI-FLOGISTIC ACTIVITY
NO883667L (en) Capsule for pharmaceutically active ingredients of a drug.
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
ES479474A1 (en) Use of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy ethylester-5-isopropylester for the preparation of cerebrally active drugs.
DK18089D0 (en) GALENIC PREPARATIONS WITH PROGRAMMED RELEASE
DE3872739D1 (en) SLOW RELEASE MEDICINAL PRODUCTS.
FI944035A0 (en) Tramadol salt containing drug with delayed release of active substance
SE8804628D0 (en) NEW COMPOUNDS
DE3585107D1 (en) SOLID DRUG PREPARATIONS WITH DIHYDROPYRIDINE AND METHOD FOR THE PRODUCTION THEREOF.
DE68909100D1 (en) Physiologically active substances, processes for their preparation and pharmaceutical compositions thereof.
AU3318389A (en) Azelastine-containing medicaments with controlled release of the active substance
ATE243499T1 (en) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION CONTAINING NIFEDIPINE AS THE ACTIVE INGREDIENT
SE8604112L (en) PHARMACEUTICAL PREPARATIONS WITH REGULATED RELEASE OF THE ACTIVE SUBSTANCE
IT1204400B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
KR890701087A (en) Formulation for oral administration of buspirone and its salts
JPS5522631A (en) Readily absorbable nifedipine preparation
AR244243A1 (en) A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
ATE227123T1 (en) TRANSDERMAL PATCH CONTAINING SOLID METHYLPHENIDATE
ATE85218T1 (en) ORAL PHARMACEUTICAL FORM FOR THE TREATMENT OF HYPERTENSION WITH DILTIAZEM HYDROCHLORIDE ONCE DAILY.
ATE212840T1 (en) SOLID MEDICINAL PREPARATIONS FOR ORAL APPLICATION WITH MODULATED RELEASE OF ACTIVE INGREDIENTS CONTAINING NICORANDIL AND METHOD FOR THE PRODUCTION THEREOF
IT1214719B (en) Controlled release cardiovascular preparations
EP0367509A3 (en) Formulations
BE880648A (en) NOVEL GALENIC FORMS OF ORAL DRUG DELIVERY, SCHEDULED RELEASE AND PREPARATION METHODS
KR920017652A (en) Α-Dihydro Ergocriptine Pharmaceutical Formulation Having Neuroprotective Activity
FR2567755B1 (en) NEW ANTI-TUMOR DRUG CONTAINING TRIACETOXY-1,8,9 ANTHRACENE AS ACTIVE INGREDIENT

Legal Events

Date Code Title Description
NUG Patent has lapsed